Fifth Third Bancorp
KRYS icon

Fifth Third Bancorp’s Krystal Biotech KRYS Stock Holding History

Fifth Third Bancorp’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.42M Buy
6,521
+596
+10% +$178K ﹤0.01% 1165
2026
Q1 		$1.53M Buy
5,925
+5,779
+3,958% +$1.54M ﹤0.01% 1372
2025
Q4 		$36K Buy
146
+15
+11% +$3.16K ﹤0.01% 1620
2025
Q3 		$23.1K Buy
131
+41
+46% +$6.14K ﹤0.01% 1840
2025
Q2 		$12.4K Sell
90
-81
-47% -$11.9K ﹤0.01% 1949
2025
Q1 		$30.8K Buy
171
+105
+159% +$17.7K ﹤0.01% 1602
2024
Q4 		$10.3K Sell
66
-28
-30% -$4.97K ﹤0.01% 1965
2024
Q3 		$17.1K Buy
94
+56
+147% +$10.8K ﹤0.01% 1828
2024
Q2 		$6.98K Buy
+38
New +$6.38K ﹤0.01% 2035

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fifth Third Bancorp's KRYS Position: Q2 2026 in Review

Fifth Third Bancorp increased its Krystal Biotech (KRYS) stake by 10% in Q2 2026, buying an estimated $178K and bringing the position to 6,521 shares worth $2.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1165.

Fifth Third Bancorp first reported a position in KRYS in Q2 2024 and has held it in 9 quarters since. 424 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Fifth Third Bancorp held 6,521 shares of Krystal Biotech worth $2.42M as of Q2 2026.
  • Fifth Third Bancorp bought 596 Krystal Biotech shares in Q2 2026, an estimated $178K.
  • Krystal Biotech made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #1165 holding.
  • Fifth Third Bancorp first reported a position in Krystal Biotech in Q2 2024 and has held it in 9 quarters since.
  • 424 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.